204 related articles for article (PubMed ID: 6476633)
1. Steady-state serum amiodarone concentrations: relationships with antiarrhythmic efficacy and toxicity.
Rotmensch HH; Belhassen B; Swanson BN; Shoshani D; Spielman SR; Greenspon AJ; Greenspan AM; Vlasses PH; Horowitz LN
Ann Intern Med; 1984 Oct; 101(4):462-9. PubMed ID: 6476633
[TBL] [Abstract][Full Text] [Related]
2. [Amiodarone therapy--behavior of serum and fatty tissue concentrations].
Gonska BD; Bethge KP; Wagner H; Bosse K; Köbberling J; Quentin CD; Kreuzer H
Klin Wochenschr; 1986 Mar; 64(5):219-26. PubMed ID: 3702280
[TBL] [Abstract][Full Text] [Related]
3. [Control of anti-arrhythmia therapy with amiodarone. Value of the determination of blood levels].
Nitsch J; Lüderitz B
Dtsch Med Wochenschr; 1984 Mar; 109(13):492-5. PubMed ID: 6423357
[TBL] [Abstract][Full Text] [Related]
4. Relationship of steady-state serum concentrations of amiodarone and desethylamiodarone to therapeutic efficacy and adverse effects.
Falik R; Flores BT; Shaw L; Gibson GA; Josephson ME; Marchlinski FE
Am J Med; 1987 Jun; 82(6):1102-8. PubMed ID: 3605129
[TBL] [Abstract][Full Text] [Related]
5. Plasma and red blood cell concentrations of amiodarone during chronic therapy.
Heger JJ; Solow EB; Prystowsky EN; Zipes DP
Am J Cardiol; 1984 Mar; 53(7):912-7. PubMed ID: 6538381
[TBL] [Abstract][Full Text] [Related]
6. Amiodarone for refractory cardiac arrhythmias: 10-year study.
Leak D; Eydt JN
CMAJ; 1986 Mar; 134(5):495-501. PubMed ID: 3948063
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics, antiarrhythmic effects, and tissue concentrations of amiodarone and desethylamiodarone in dogs with acute coronary artery occlusion.
Somani P; Simon VA; McManus K
Can J Cardiol; 1985 Jan; 1(1):56-65. PubMed ID: 3850764
[TBL] [Abstract][Full Text] [Related]
8. Amiodarone: clinical efficacy and toxicity in 96 patients with recurrent, drug-refractory arrhythmias.
Fogoros RN; Anderson KP; Winkle RA; Swerdlow CD; Mason JW
Circulation; 1983 Jul; 68(1):88-94. PubMed ID: 6851057
[TBL] [Abstract][Full Text] [Related]
9. High incidence of clinical and subclinical toxicity associated with amiodarone treatment of refractory tachyarrhythmias.
Anastasiou-Nana MI; Anderson JL; Nanas JN; Lutz JR; Smith RA; Anderson KP; Crapo RO; Call NB
Can J Cardiol; 1986; 2(3):138-45. PubMed ID: 2941121
[TBL] [Abstract][Full Text] [Related]
10. Toxic and therapeutic effects of amiodarone in the treatment of cardiac arrhythmias.
Greene HL; Graham EL; Werner JA; Sears GK; Gross BW; Gorham JP; Kudenchuk PJ; Trobaugh GB
J Am Coll Cardiol; 1983 Dec; 2(6):1114-28. PubMed ID: 6685151
[TBL] [Abstract][Full Text] [Related]
11. Relation between amiodarone and desethylamiodarone plasma concentrations and electrophysiologic effects, efficacy and toxicity.
Greenberg ML; Lerman BB; Shipe JR; Kaiser DL; DiMarco JP
J Am Coll Cardiol; 1987 May; 9(5):1148-55. PubMed ID: 3571754
[TBL] [Abstract][Full Text] [Related]
12. Long-term efficacy and toxicity of high-dose amiodarone therapy for ventricular tachycardia or ventricular fibrillation.
Morady F; Sauve MJ; Malone P; Shen EN; Schwartz AB; Bhandari A; Keung E; Sung RJ; Scheinman MM
Am J Cardiol; 1983 Nov; 52(8):975-9. PubMed ID: 6637851
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of amiodarone therapy in the treatment of drug-resistant cardiac arrhythmias: long-term follow-up.
Peter T; Hamer A; Mandel WJ; Weiss D
Am Heart J; 1983 Oct; 106(4 Pt 2):943-50. PubMed ID: 6613841
[TBL] [Abstract][Full Text] [Related]
14. The antiarrhythmic efficacy of amiodarone and desethylamiodarone, alone and in combination, in dogs with acute myocardial infarction.
Nattel S; Davies M; Quantz M
Circulation; 1988 Jan; 77(1):200-8. PubMed ID: 2446801
[TBL] [Abstract][Full Text] [Related]
15. Amiodarone therapy for life threatening or refractory cardiac arrhythmias.
Johns JA; Harper RW; Currie PJ; Federman J; Anderson ST; Pitt A
Aust N Z J Med; 1983 Jun; 13(3):248-56. PubMed ID: 6579938
[TBL] [Abstract][Full Text] [Related]
16. Suppression of arrhythmias within hours after a single oral dose of amiodarone and relation to plasma and myocardial concentrations.
Escoubet B; Coumel P; Poirier JM; Maison-Blanche P; Jaillon P; Leclercq JF; Menasche P; Cheymol G; Piwnica A; Lagier G
Am J Cardiol; 1985 Mar; 55(6):696-702. PubMed ID: 3976511
[TBL] [Abstract][Full Text] [Related]
17. Serum concentrations of amiodarone during long term therapy. Relation to dose, efficacy and toxicity.
Stäubli M; Bircher J; Galeazzi RL; Remund H; Studer H
Eur J Clin Pharmacol; 1983; 24(4):485-94. PubMed ID: 6861863
[TBL] [Abstract][Full Text] [Related]
18. Concentration response relationships of amiodarone and desethylamiodarone.
Connolly SJ; Gupta RN; Hoffert D; Roberts RS
Am Heart J; 1988 Jun; 115(6):1208-13. PubMed ID: 3376838
[TBL] [Abstract][Full Text] [Related]
19. [Plasma concentrations and amiodarone/desethylamiodarone relations in patients subjected to chronic treatment].
Ortiz M; Gaete L; Asenjo R; Fernández F; Saavedra I
Rev Med Chil; 1996 Jan; 124(1):77-82. PubMed ID: 8762622
[TBL] [Abstract][Full Text] [Related]
20. Clinical pharmacokinetics and efficacy of amiodarone for refractory tachyarrhythmias.
Haffajee CI; Love JC; Canada AT; Lesko LJ; Asdourian G; Alpert JS
Circulation; 1983 Jun; 67(6):1347-55. PubMed ID: 6851030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
